Tags: Drug.

Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville Pennsylvania.

ATC prefix
none
CAS number
705287-60-1
FDA UNII code
V43X8G4797

Loading...

This page contains content from the copyrighted Wikipedia article "Stamulumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.